ESC 365 - ENVAD-HF: sacubitril/valsartan in Heartmate 3 LVAD recipients

ESC2025 Premium Access

ENVAD-HF: sacubitril/valsartan in Heartmate 3 LVAD recipients

Session: Late-Breaking Clinical Trials: advances in heart failure care

Topic: Ventricular Assist Devices

Speaker: Professor M. Cikes (Zagreb, HR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)

75 presentations

28 followers

2 more presentations in this session

Lifetime Benefits of Combination Therapy in HFpEF

Speaker: Doctor M. Vaduganathan (Boston, US)

LOT-MDR: Loop diuretic dose intensification versus adjuvant thiazide for diuretic resistance in acute heart failure

Speaker: Professor Z. Cox (Nashville, US)

Access the full session

Late-Breaking Clinical Trials: advances in heart failure care

Speakers: Professor M. Cikes, Doctor M. Vaduganathan, Professor Z. Cox

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources